ONYX — Onyx Biotec Balance Sheet
0.000.00%
- IN₹944.69m
- IN₹1.23bn
- IN₹537.49m
Annual balance sheet for Onyx Biotec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 0.136 | 0.074 | 14.7 |
Net Total Accounts Receivable | |||
Net Total Receivables | 110 | 53.2 | 156 |
Total Inventory | |||
Total Other Current Assets | |||
Total Current Assets | 144 | 146 | 296 |
Net Property, Plant And Equipment | 213 | 425 | 435 |
Other Long Term Assets | |||
Total Assets | 368 | 587 | 741 |
Accounts Payable | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 100 | 202 | 226 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Total Other Liabilities | |||
Total Liabilities | 205 | 405 | 493 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 164 | 182 | 249 |
Total Liabilities & Shareholders' Equity | 368 | 587 | 741 |
Total Common Shares Outstanding |